2002
DOI: 10.1006/exmp.2002.2425
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Lumican in Thickened Intima and Smooth Muscle Cells in Human Coronary Atherosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
29
0
1

Year Published

2003
2003
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(34 citation statements)
references
References 25 publications
4
29
0
1
Order By: Relevance
“…The arrowhead indicates the level of the intima/media boundary. Immunoreactivity corresponding to the class II SRL proteoglycan lumican has been observed in both atherosclerotic lesions and intimal hyperplasia (24). Consistent with these findings, by mass spectrometry lumican was detected in intimal hyperplasia in most of the specimens analyzed here.…”
Section: Fig 2 Removal Of Thickened Intima For Proteomic Analysissupporting
confidence: 90%
“…The arrowhead indicates the level of the intima/media boundary. Immunoreactivity corresponding to the class II SRL proteoglycan lumican has been observed in both atherosclerotic lesions and intimal hyperplasia (24). Consistent with these findings, by mass spectrometry lumican was detected in intimal hyperplasia in most of the specimens analyzed here.…”
Section: Fig 2 Removal Of Thickened Intima For Proteomic Analysissupporting
confidence: 90%
“…Our previous results suggesting that fibromodulin is involved in plaque development by affecting ECM structure and lipid retention, together with previous publications discussing lumican expression in healthy and pathological vasculature, [17][18][19][20][21] raise the question of possible contribution by these SLRPs to atherosclerotic plaque development and its stability. In the present study we have thus for the first time analyzed the expression of fibromodulin and lumican in human carotid plaques in relation to the occurrence of preoperative cerebrovascular symptoms (namely strokes, transient ischemic attacks (TIA) or amaurosis fugax) and postoperative cardiovascular (CV) events.…”
Section: Introductionmentioning
confidence: 66%
“…17 In addition, lumican has been shown to be expressed in intimal vascular SMCs in human coronary atherosclerosis 18 and, as compared to arteries from healthy subjects, overexpressed in arteries from patients with coronary artery dis-ease, 19 in femoral arteries with atherosclerotic plaques from patients with peripheral occlusive arterial disease 20 and in aortic valves from patients with degenerative aortic stenosis 21 .…”
Section: Discussionmentioning
confidence: 99%
“…cornea (Kao and Liu, 2002) Cornea plana (Pellegata et al, 2000) Osteoarthritis Lumican Structural component of e.g. cornea (Kao and Liu, 2002) Myopia Majava et al, 2007a) Fibrosis and tumor growth (Naito, 2005); atherosclerosis (Onda et al, 2002) Osteoadherin Promotes ␣v/␀3-integrin mediated cell binding (Wendel et al, 1998); regulation of complement activation (Sjöberg et al, 2009) PRELP Anchors basement membranes to the underlying connective tissue (Bengtsson et al, 2002) Myopia (Majava et al, 2007a) Epiphycan Involved in chondrogenesis (Knudson and Knudson, 2001) Opticin Component of the vitreous humour of the eye (Reardon et al, 2000) and cartilage (Monfort et al, 2008) Myopia (Majava et al, 2007a); primary open angle glaucoma (Acharya et al, 2007) Osteoglycin/Mimecan Component of the vascular wall (Shanahan et al, 1997); regulation of collagen fibrillogenesis (Tasheva et al, 2002) Chondroadherin Component of the cornea, brain, and skeletal muscle, retina and lens (Tasheva et al, 2004); regulates chondrocyte growth and proliferation (Shen et al, 1998) Nyctalopin Essential for retinal synaptic transmission …”
Section: Targeting Extracellular Matrix Molecules In Pharmacotherapymentioning
confidence: 99%